Analystreport

Esperion Therapeutics Inc (NASDAQ: ESPR) was downgraded by analysts at Northland Securities to a "hold" rating. They now have a $60.00 price target on the stock.

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com